| Date | Time | Source | Headline | Symbol | Company |
| 06/07/2024 | 2:15PM | iHub Newswire | FeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio | | |
| 12/06/2011 | 8:49AM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:GILD | Gilead Sciences Inc |
| 12/06/2011 | 7:31AM | Zacks | Spotlight on Hepatitis-C Market - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 12/05/2011 | 8:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 12/05/2011 | 8:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 12/05/2011 | 8:30AM | Business Wire | Gilead’s Boosting Agent, Cobicistat, Meets 48-Week Primary Objective in Pivotal Phase 3 Study | NASDAQ:GILD | Gilead Sciences Inc |
| 12/01/2011 | 9:00AM | Marketwired | Direction of Market Influences - Report Highlights Gilead Sciences, Inc. and Bristol Myers Squibb Co. | NASDAQ:GILD | Gilead Sciences Inc |
| 11/29/2011 | 10:00AM | Zacks | Gilead's Eviplera Cleared in EU - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 11/28/2011 | 4:30PM | Business Wire | Gilead Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference on Tuesday, November 29 | NASDAQ:GILD | Gilead Sciences Inc |
| 11/28/2011 | 1:00PM | Business Wire | Gilead Receives European Marketing Authorization for Eviplera®, a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 I... | NASDAQ:GILD | Gilead Sciences Inc |
| 11/28/2011 | 9:31AM | PR Newswire (US) | Critical Alerts for Amazon.com, Gilead, Lennar, Big Lots, and Collective Brands Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 11/25/2011 | 2:17PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/22/2011 | 9:15AM | Zacks | Gilead to Buy Pharmasset for $11B - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 11/22/2011 | 4:06AM | Zacks | Company News for November 22, 2011 - Corporate Summary | NASDAQ:GILD | Gilead Sciences Inc |
| 11/22/2011 | 3:30AM | Zacks | The Zacks Analyst Blog Highlights: Gilead Sciences, Pharmasset, Nasdaq Biotechnology ETF, InterMune & Dendreon - Press Releases | NASDAQ:GILD | Gilead Sciences Inc |
| 11/21/2011 | 2:54PM | PR Newswire (US) | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Pharma... | NASDAQ:GILD | Gilead Sciences Inc |
| 11/21/2011 | 9:00AM | Marketwired | Steps in the Right Direction - Featured Research on Poniard Pharmaceuticals, Inc. and Gilead Sciences, Inc. | NASDAQ:GILD | Gilead Sciences Inc |
| 11/21/2011 | 7:12AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/21/2011 | 7:00AM | Business Wire | Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion | NASDAQ:GILD | Gilead Sciences Inc |
| 11/21/2011 | 4:01AM | Zacks | "Super-Committee" Anything But - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 11/21/2011 | 3:58AM | Dow Jones News | Actelion To Appeal US Verdict In Asahi Kasei Licencing Dispute | NASDAQ:GILD | Gilead Sciences Inc |
| 11/21/2011 | 3:56AM | Zacks | Ahead of Wall Street - November 21, 2011 - Ahead of Wall Street | NASDAQ:GILD | Gilead Sciences Inc |
| 11/20/2011 | 7:00PM | Zacks | Biotech Investing Lessons: GILD Buys VRUS - Tactical Trading | NASDAQ:GILD | Gilead Sciences Inc |
| 11/17/2011 | 6:00AM | Zacks | Gilead Steady at Neutral - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 11/16/2011 | 10:00AM | Zacks | Gilead, JNJ HIV Deal Finalized - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 11/15/2011 | 4:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/15/2011 | 4:05PM | Business Wire | Gilead Sciences Finalizes Agreement with Tibotec Pharmaceuticals to Develop & Commercialize a Single-Tablet Regimen of Prezis... | NASDAQ:GILD | Gilead Sciences Inc |
| 11/14/2011 | 4:30PM | Business Wire | Gilead Sciences to Present at the Lazard Capital Markets 8th Annual Healthcare Conference on Tuesday, November 15 | NASDAQ:GILD | Gilead Sciences Inc |
| 11/09/2011 | 5:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 11/08/2011 | 4:30PM | Business Wire | Gilead Sciences to Present at the 2011 Credit Suisse Healthcare Conference on Wednesday, November 9 | NASDAQ:GILD | Gilead Sciences Inc |